BioMed Research International / 2015 / Article / Tab 3

Review Article

Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy

Table 3

Relative risk results of the systematic review. Note: Pawar and colleagues (the SAMITAL study) were excluded due to low and methodological uncertainty.

StudyLower CIUpper CIRelative risk

Bao et al. [21]1240.543.291.34
Belcaro et al. [22]800.755.332.00
Brooker et al. [23]660.801.130.95
Costa Fortes et al. [24]560.250.810.45
Pawar et al. [27]()N/AN/AN/A
Pommier et al. [25]2540.490.890.66
Tröger et al. [26]2200.700.900.79
Average8000.592.061.03

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.